| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/11/2009 | CN100460414C Stable vitamin B6 derivative |
| 02/11/2009 | CN100460412C Process for preparing amine platinum complexes |
| 02/11/2009 | CN100460405C Polyacid compound for resisting penicillin streptococcus pneumoniae (PRSP) and preparing method thereof |
| 02/11/2009 | CN100460397C Sulfur-containing quinoxaline dioxide, method for producing same and their application in preparing low-oxygen selective anti-tumor medicament |
| 02/11/2009 | CN100460395C Aromatic-cyclo and heterocyclo acylmethyl imidazole salts compound and method for preparing same |
| 02/11/2009 | CN100460391C Chemical compounds. |
| 02/11/2009 | CN100460387C S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate hydrochloride crystalline salt |
| 02/11/2009 | CN100460383C Compound and preparation method thereof and application in pharmacy |
| 02/11/2009 | CN100460017C Total arasaponin precursor liposome and prepn process thereof |
| 02/11/2009 | CN100459995C Effective gauze and ointment for treating burn and scald and preparation method thereof |
| 02/11/2009 | CN100459991C External use drug for treating burn, bedsore, chronic ulcer and etc. and preparation method thereof |
| 02/11/2009 | CN100459987C Effective part of astragalus, preparing method and application in pharmacy |
| 02/11/2009 | CN100459984C Medicinal composition for pet care and preparing method thereof |
| 02/11/2009 | CN100459982C Dispersible tablet of doxifluridine |
| 02/11/2009 | CN100459981C Pharmaceutical composition for treating traumatic injury |
| 02/11/2009 | CN100459980C 7-Hydroxyepiandrosterone having neuroprotective activity |
| 02/11/2009 | CN100459979C Methionine vitamin B1 freeze dried composition and preparation method thereof |
| 02/11/2009 | CN100459978C Rosiglitazone slow-release tablet and preparation method thereof |
| 02/11/2009 | CN100459977C Skin penetrating paste of indomethacin albuterol |
| 02/11/2009 | CN100459976C Compound paclitaxel preparation containing phospholipid dispersant and preparation method thereof |
| 02/11/2009 | CN100459975C Usage of D-glyceric acid or the salt thereof for preparing medical preparation strengthening alcohol metabolism |
| 02/11/2009 | CN100459973C External-use ointment and preparing method thereof |
| 02/11/2009 | CN100459958C Chinese medicine heat therapy eyeshade and its medicine |
| 02/11/2009 | CN100459880C Health food containing chitin and preparing method thereof |
| 02/10/2009 | US7488848 Alpha ketoamide compounds as cysteine protease inhibitors |
| 02/10/2009 | US7488844 Therapeutic agents |
| 02/10/2009 | US7488832 e.g. N-[amino(imino)methyl]-2-[2-(4-phenoxyphenyl)-5-phenyl-1H-pyrrol-1-yl]acetamide; beta -amyloid deposits and neurofibrillary tangles; cognition activator, neurodegenerative diseases; Alzheimer's disease, Down's syndrome |
| 02/10/2009 | US7488831 pyrazole compound (e.g. 5-hydroxy-3-trifluoromethylpyrazole) is reacted with a sulfur compound (e.g. 2-ethylthiophenol) in the presence of a base and formaldehyde, to produce a 5-hydroxy-4-thiomethylpyrazole |
| 02/10/2009 | US7488829 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 02/10/2009 | US7488827 Muscle relaxants; respiratory system disorders; asthma;COPD; emphysema; bronchitis |
| 02/10/2009 | US7488823 4-anilino quinazolines substituted with a N'-cyanoguanidinoalkyl group; antiproliferative, anticancer, antiinflammatory |
| 02/10/2009 | US7488822 Cyclocarbamate derivatives as progesterone receptor modulators |
| 02/10/2009 | US7488817 Metal complex protein kinase inhibitors |
| 02/10/2009 | US7488811 Lacking cladinose in position 3, de(N-methyl)-descladinosyl-9-dihydro-erythromycin A; free of antibiotic properties; diseases related to an impaired cellular functionality of neutrophils, for instance rheumatoid arthritis, reperfusion ischaemia injury, septic shock, atherosclerosis |
| 02/10/2009 | US7488803 Anticancer agents; two primordial germ cell-specific expressed genes, Fragilis and Stella; as markers for primordial germ cells |
| 02/10/2009 | US7488759 Malic acid addition salts of terbinafine |
| 02/10/2009 | US7488758 Levalbuterol hydrochloride polymorph B |
| 02/10/2009 | US7488757 Invisible antimicrobial glove and hand antiseptic |
| 02/10/2009 | US7488756 Use of non-competitive and selective GluR5 antagonists as glutamate receptor modulating compounds |
| 02/10/2009 | US7488755 NMDA receptor agonist; neurodegenerative diseases, cognition activator; autism, schizophrenia, Alzheimer's disease; glycinergic and/or glutaminergic transmission activator |
| 02/10/2009 | US7488754 Method for the treatment of polycystic kidney disease |
| 02/10/2009 | US7488753 from plants in sapindaceae family, such as Xanthoceras sorbifolia; ovarian, skin, bladder, prostate, leukocytes, and bone cancer cell growth inhiitor |
| 02/10/2009 | US7488752 Thrombin receptor antagonists |
| 02/10/2009 | US7488751 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan |
| 02/10/2009 | US7488750 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 02/10/2009 | US7488749 Therapy of diseases of the eye, the inner ear and the central nervous system |
| 02/10/2009 | US7488748 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 02/10/2009 | US7488747 Pyrrole and pyrazole DAAO inhibitors |
| 02/10/2009 | US7488746 Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 02/10/2009 | US7488745 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 02/10/2009 | US7488744 Indole-type derivatives as inhibitors of p38 kinase |
| 02/10/2009 | US7488743 Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof |
| 02/10/2009 | US7488742 Therapy for thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents |
| 02/10/2009 | US7488741 4-Aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 02/10/2009 | US7488740 Substituted quinolin-4-ylamine analogues |
| 02/10/2009 | US7488739 platelet aggregation inhibitors; anti-platelet agent with a high safety profile with a smaller adverse bleeding effect; P2Y12 inhibitor; (2S)-2-({[7-(cyclohexylamino)-1-cyclopentyl-6-fluoro-4-oxo-1,4-dihydroquinolin-3-yl]carbonyl}amino)butanedioic acid |
| 02/10/2009 | US7488738 Such as 4-({4-[[(4-Amino-2,3,5,6-tetramethylanilino)acetyl]-(methyl)amino]-1-piperidino}methyl)benzamide which has neuroprotective effects by inducing calcium binding proteins |
| 02/10/2009 | US7488737 Each compound having an azabicyclic ring attached via a ring N or amino group; neuroprotectants; neurodegenerative diseases, analgesics, psychological disorders; e.g. 5-Methoxy-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxamide; ligands for nicotinic acetylcholine receptors |
| 02/10/2009 | US7488736 serotonin receptor agonist and antagonist; antidepressant, anxoilytic agent, neurodegenerative diseases; neurodegenerative disease, cognition disorders, irritable bowel syndrome, nausea; 6,7-Dihydro-4-hydroxy-7-isopropyl-6-oxo-N-(3-(piperidin-1-yl)propyl)thieno[2,3-b]pyridine-5-carboxamid potassium salt |
| 02/10/2009 | US7488735 antagonists of M3 muscarinic receptors; N-(1-Azabicyclo[2.2.2]oct-3-yl)-2-hydroxy-2,2-dithien-2-ylacetamide; respiratory disorders, urological disorders, gastrointestinal disorders, cardiovascular disorders; alkylation |
| 02/10/2009 | US7488734 Anticancer agents; hormone replacement therapy; contraceptives |
| 02/10/2009 | US7488733 For improving perception, concentration, learning or memory; 2-(Cyclopentylmethyl)-4-[(fluorophenyl)amino]6-oxo-1,6-dihydro-5-pyrimidinecarbonitrile; amination of methyl 2-cyano propenoate derivatives, cyclization using amidinehydrochloride derivatives |
| 02/10/2009 | US7488731 Arylpiperazinyl compounds |
| 02/10/2009 | US7488730 N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-phenyl-1-piperazinealkylamide derivatives, and therapeutic use thereof as 5-HT7 receptor ligands |
| 02/10/2009 | US7488729 Polymorphic forms of ziprasidone and its hydrochloride salt and process for preparation thereof |
| 02/10/2009 | US7488728 Pyridinylmorpholine derivatives |
| 02/10/2009 | US7488727 Thiazole compounds useful as inhibitors of protein kinase |
| 02/10/2009 | US7488726 Useful for treating or preventing a variety of antibiotic resistant microbial infections; for example, a 25-O-deacetyl-25-(2'',3''-dihydroxypropylcarbonoxy)-benzoxazinorifamycin |
| 02/10/2009 | US7488725 To treat diabetes, especially type II diabetes including complications of diabetes; synergistic |
| 02/10/2009 | US7488724 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors |
| 02/10/2009 | US7488723 Treating eye disorders |
| 02/10/2009 | US7488722 Anxiolytic Marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods |
| 02/10/2009 | US7488721 Real time methylumbelliferone-based assay |
| 02/10/2009 | US7488720 A1 adenosine receptor agonists |
| 02/10/2009 | US7488716 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 02/10/2009 | US7488715 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 02/10/2009 | US7488714 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 02/10/2009 | US7488498 Controlled release nateglimide formulation; reducing blood glucose concentration |
| 02/10/2009 | US7488497 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID |
| 02/10/2009 | US7488496 Antiulcer agents (H2-antagonists such as ranitidine and cimetidine); for treating osteoporosis |
| 02/10/2009 | US7488495 Ion binding polymers and uses thereof |
| 02/10/2009 | US7488494 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 02/10/2009 | US7488493 Using mixture of oil and brines |
| 02/10/2009 | US7488469 Delivery of caffeine through an inhalation route |
| 02/10/2009 | CA2562418C Sustained release formulation for oral administration of hmg-coa reductase inhibitor and method for the preparation thereof |
| 02/10/2009 | CA2495925C Integrated infusion and aspiration system and method |
| 02/10/2009 | CA2494506C Development of muscle mass in a mammal |
| 02/10/2009 | CA2458067C Use of flibanserin in the treatment of sexual disorders |
| 02/10/2009 | CA2451229C Indole derivatives |
| 02/10/2009 | CA2429574C Sterilisation of pharmaceuticals |
| 02/10/2009 | CA2427199C Process for the production of ceftiofur sodium salt |
| 02/10/2009 | CA2389709C Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 02/10/2009 | CA2386690C Pharmaceutical tramadol salts |
| 02/10/2009 | CA2385732C Bicyclic compounds composition and method for stabilizing the same |
| 02/10/2009 | CA2383659C Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt) |
| 02/10/2009 | CA2380904C Nsaid and efgr kinase inhibitor containing composition for the treatment or inhibition of colonic polyps and colorectal cancer |
| 02/10/2009 | CA2355633C Skin care compositions containing cis-9, trans-11 linoleic acid |
| 02/10/2009 | CA2352561C Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy |
| 02/10/2009 | CA2349452C Therapeutic agents for drug dependence |
| 02/10/2009 | CA2346988C Pharmaceutical formulation comprising omeprazole |